Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging.

Clin Res Cardiol · 2023 · PMC9998574 · PMID 35666277

Europe PMC DOI

hedged sentence

0.0960

closest p · 1.9× alpha

0.0960

boldest claim

The sentences

showed a trendp = 0.096so close (0.05 < p ≤ 0.1)

Clinical symptoms were assessed based on NYHA classification and showed a trend towards improvement in group A without reaching statistical significance compared to a trend towards significant worsening in groups B, ( p = 0.096 in group A vs p = 0.007 in group B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.